GeneFab is a cell and gene therapy CDMO founded in 2023, headquartered in Alameda, California, making advanced therapies accessible through specialized partnerships.
Subscribe to see Genefab’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Genefab is a biotech company headquartered in United States. Xcout tracks 11 named people at Genefab, including Philip Lee (Chief Executive Officer). Xcout recorded 5 job postings from Genefab in the last 90 days.
5 more named people on record for Genefab, with roles, board committees and tenure — see the full roster →
Xcout recorded 5 job postings from Genefab in the last 90 days, from a hiring record Xcout has kept since September 2026.
The weekly hiring trend, the roles and locations behind it — see Genefab's hiring signals →
A few of Genefab's closest competitors — see the full list of competitors and alternatives →
ElevateBio is a biotechnology company that builds and operates cell and gene therapy companies and provides development, manufacturing, and technology capabilities through its platform, including BaseCamp. It serves biotech and pharmaceutical organizations developing advanced therapies, as well as supporting the creation of new therapeutic companies.
Kincell Bio operates as a cell therapy contract development and manufacturing organization (CDMO) that serves biopharmaceutical clients. The company provides GMP manufacturing, process and analytical development, chemistry, manufacturing, and controls (CMC) strategy, and characterization and release testing to support cell therapy programs from early development through commercial launch.
Andelyn Biosciences is a cell and gene therapy contract development and manufacturing organization (CDMO) that provides viral vector and plasmid manufacturing, process development, and laboratory services.
AGC Biologics is a global contract development and manufacturing organization (CDMO) that provides services for protein-based biologics and advanced therapies, including mammalian and microbial production, viral vectors, cell therapy, plasmid DNA, and mRNA. The company supports biopharmaceutical developers by offering process development, analytical formulation, cGMP manufacturing, and fill-finish services to help bring life-changing treatments to market.
Shanghai OBiO Technology (Group) Corp., Ltd. is a biotechnology contract development and manufacturing organization (CDMO/CRO) focused on gene and cell therapy services, including viral-vector development and manufacturing. It serves pharmaceutical and biotechnology companies, academic institutions, and research organizations developing gene-therapy and related biologics products.
Forge Biologics Holdings, LLC is the parent company of Forge Biologics, a U.S.-based contract development and manufacturing organization focused on gene therapies, particularly adeno-associated virus (AAV) programs. It provides process development, analytical services, and clinical and commercial manufacturing to biotechnology and pharmaceutical companies.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Genefab? Suggest a correction
Post the link and the card appears automatically — each network fetches the image itself.